Skip to main content
Default Image

Where next for the New Economy movement?

Eli Feghali writes in Open Democracy on ‘where next for the New Economy movement?’ In this article, Feghali highlights the work of the Democracy Collaborative with the Preston Model:  

These policy victories could be a sign of the mass appeal of new economy values and ideas. That certainly seems to be the case in parts of UK politics, where the Labour party has adopted policies and narratives about democratizing the economy in their national party platform. This development was inspired in part by the success of the “Preston model”—an economic development framework which gives priority to building an ecosystem of institutions that work together to build and circulate wealth within the community. This model (named after the city of Preston where it’s been tested since around 2013) was itself inspired by a US experiment, the Evergreen Cooperatives in Cleveland, Ohio, a network of worker cooperatives financed and supported by anchor institutions like hospitals and schools in the community.

Read more in Open Democracy

Publication date: 2018-07-16
Parent publication: Open Democracy
Publication URL: Where next for the New Economy movement?

More related work

March 19, 2020
Default Image

Protect the vulnerable, advance the democratic economy: Our statement on the COVID-19 crisis

We are in a period of breakdown, in which all that is wrong with the current system is now being laid bare. Rather than rebuild what we now clearly see should never have been, we must lead the construction out of this crisis of something new.

read more
March 18, 2020
Default Image

HAN Public Comments on Fair Housing Act Proposed Changes

The Healthcare Anchor Network submitted public comments to the Department of Housing and Urban Development (HUD), expressing our opposition to HUD’s proposed changes to the 2015 Affirmatively Furthering Fair Housing rule.

read more
March 17, 2020
An array of prescription medications on shelves

Online press briefing: Vaccines—The COVID-19 Case for Public Pharmaceutical Research and Development

Leading experts believe that it is the government’s responsibility to ensure widespread access to safe and effective vaccines that are developed with taxpayer money. In this virtual press briefing, hear why the U.S. government should develop and manufacture vaccines and other essential medicines so that we get the medicines we need, when we need them and at prices we can afford.

read more